SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-097470
Filing Date
2016-02-16
Accepted
2016-02-16 18:16:44
Documents
2
Period of Report
2016-02-11

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2954
2 EX-24.1 ex-24d1.htm EX-24.1 9070
  Complete submission text file 0001104659-16-097470.txt   13456
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE, BLDG. 1400E CAMBRIDGE MA 02139
Business Address
Cunnane Deirdre A. (Reporting) CIK: 0001666942 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37467 | Film No.: 161430833